Steve Elms insider trades
Open-market stock purchases and sales by Steve Elms, Unknown at Adma Biologics, Inc, from SEC Form 4 filings since Feb 11, 2010.
Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -52%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 6, 2026 | ADMA Adma Biologics, Inc | Bought | $108K |
| Mar 5, 2026 | ADMA Adma Biologics, Inc | Bought | $110K |
| Feb 9, 2026 | ADMA Adma Biologics, Inc | Bought (not open market) | — |
| Feb 9, 2026 | ADMA Adma Biologics, Inc | Bought (not open market) | — |
| Nov 17, 2025 | MRKR Marker Therapeutics, Inc | Bought (not open market) | — |
| Nov 17, 2025 | MRKR Marker Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- ADMA Adma Biologics, Inc: 2 buys, 8 sales, last Mar 6, 2026
- MRKR Marker Therapeutics, Inc: 2 buys, last Nov 17, 2025
- ELEV Elevation Oncology, Inc: other filings, last Jul 23, 2025
- ZSAN Zosano Pharma Corp: other filings, last Jun 10, 2021
- LOXO Loxo Oncology, Inc: 1 buy, last Feb 15, 2019
- PTX Pernix Therapeutics Holdings, Inc: 4 buys, last May 26, 2016
- CDTX Cidara Therapeutics, Inc: other filings, last Apr 20, 2015
- AMBI Ambit Biosciences Corp: 1 buy, last Sep 2, 2014
- NONE Adma Biologics, Inc: other filings, last Apr 4, 2012
- MAPP MAP Pharmaceuticals, Inc: 1 sale, last May 20, 2010